Patient-reported outcomes in epilepsy: a case study exploring their usage and impact [0.03%]
癫痫的患者报告结果：一项探索其使用和影响的案例研究
Simona Lattanzi,Angela La Neve
Simona Lattanzi
Background: This study aimed to obtain insights from epilepsy specialists on the use of Patient-Reported Outcome (PRO) measures and how they can affect the management of people with epilepsy and healthcare resource utiliz...
Costs and benefits in patients with NYHA class III heart failure treated with CardioMEMS in Italy [0.03%]
意大利NYHA III级心力衰竭患者使用CardioMEMS的成本效益分析
Andrea Messori,Maria Rita Romeo,Valeria Fadda et al.
Andrea Messori et al.
Background: CardioMEMS is a device suitable for telemedicine that is currently being evaluated by the Regional Health Technology Assessment (HTA) Committee of Tuscany. Two detailed HTA reports are available in the special...
Scompenso cardiaco e impatto economico: un’analisi nella reale pratica clinica in Italia [0.03%]
心脏补偿和经济影响：意大利实际临床实践中的分析
Melania Dovizio,Melania Leogrande,Luca Degli Esposti
Melania Dovizio
Dati regionali e loro ruolo nella pianificazione, nella programmazione e nel controllo a livello regionale [0.03%]
区域数据及其在区域性计划、规划和控制中的作用
Irene Marzona,Paolo Stella,Gianluca Trifirò et al.
Irene Marzona et al.
The socioeconomic burden of adult attention-deficit/hyperactivity disorder in Spain [0.03%]
西班牙成人注意缺陷多动障碍的社会经济负担
María Merino,Paulina Maravilla-Herrera,Teresa Martín Lorenzo et al.
María Merino et al.
Introduction: The symptoms of attention-deficit/hyperactivity disorder (ADHD) in adults highly interfere with function in multiple dimensions, increasing the economic burden associated with ADHD. The aim of this study was...
The role and impact of health economics in the optimization of patient care in osteoarthritis: insights from a practical example [0.03%]
骨关节炎患者护理优化的卫生经济学作用和影响：一个实际案例的启示
Mickaël Hiligsmann,Olivier Bruyère
Mickaël Hiligsmann
Osteoarthritis (OA) is a degenerative joint disease with a substantial global burden, causing chronic pain and reduced quality of life. Managing OA efficiently while maximizing healthcare resources is crucial. Health economics and health te...
Prontuari Terapeutici Regionali in Italia: stato dell’arte e prospettive future [0.03%]
意大利地区治疗档案现状与未来展望
Alberto Bortolami,Claudio Jommi,Filippo Bresciani et al.
Alberto Bortolami et al.
Costo per Number Needed to Treat (NNT) di upadacitinib nel trattamento dei pazienti bio-exposed con rettocolite ulcerosa attiva da moderata a grave [0.03%]
在治疗中度至重度活动性溃疡性结肠炎的生物暴露患者中，upadacitinib的所需治疗人数(NNT)的成本
Flavio Caprioli,Massimo Claudio Fantini,Francesca Marando et al.
Flavio Caprioli et al.
Francesca Patarnello
Francesca Patarnello
Costo per NNT di upadacitinib nel trattamento dei pazienti con dermatite atopica da moderata a severa in Italia [0.03%]
意大利乌帕西替尼治疗中度至重度特应性皮炎患者的NNT成本
Andrea Chiricozzi,Antonio Costanzo,Anna Levi et al.
Andrea Chiricozzi et al.